Eli Lilly Gets Expanded Label Approval From FDA for Alopecia Drug
By Elias SchisgallEli Lilly received expanded label approval from the Food and Drug Administration for Olumiant, a drug for pediatric patients 12 years of age or older with severe alopecia areata.The company said Friday that the FDA had approved the expanded U.S. label for the drug, known generical…